Back to results
US 2006/0188984 A1Published application
Method of providing readily available cellular material derived from cord blood, and a composition thereof
OwnerDonnie Ruddinventor
Life of this patent
Estimating the term…
Abstract
The present invention is directed to the TVEMF-expansion of mammalian cord blood stem cells, preferably CD34+/CD38− cells, to compositions resulting from the TVEMF-expanded cells, and to a method of treating disease or repairing tissue with the compositions. Various benefits and advantages to the compositions of the present invention are discussed herein.
Claims53
Cord blood stem cells from a mammal,
- wherein said cord blood stem cells are in a number per volume that is at least 7 times greater than naturally-occurring cord blood;
- and
- wherein the cord blood stem cells have a three-dimensional geometry and cell-to-cell support and cell-to-cell geometry that is essentially the same as stem cells of naturally-occurring cord blood.
Cord blood stem cells from a mammal, wherein said cord blood stem cells are TVEMF-expanded.
A process for preparing a cord blood stem cell composition comprising the steps of:
- a. placing a cord blood mixture in a culture chamber of a TVEMF-bioreactor;
- and
- b. subjecting the cord blood mixture to a TVEMF and TVEMF-expanding the cord blood stem cells to prepare the cord blood stem cell composition.
Dependencies are inferred from the claim text.